Vetter Introduces Next-Generation Closure System for Injectable Products

Vetter has unveiled plans for V-OVS® next, a groundbreaking evolution of its trusted closure system for sterile injectables. Building on decades of proven market success, this innovative design is set to redefine Luer Lock applications with advanced user-friendly features. Guided by customer feedback and shifting market demands, V-OVS® next introduces an improved intuitive opening mechanism, enhanced gripping surfaces, and a robust locking system. Its reduced size makes it ideal for smaller syringe formats, offering greater versatility for a broader range of injectable products.

“We are thrilled to bring V-OVS® next to life, as it combines cutting-edge tamper-evident features with seamless handling improvements,” said Tobias Nemeth, Director of Primary Packaging Service & Projects at Vetter. A recent human factors study involving frontline clinical users confirmed the design’s practicality, paving the way for its anticipated 2027 launch. Vetter aims to continue providing both V-OVS® and V-OVS® next, ensuring customers have flexible options tailored to their needs.